RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.045
-0.025 (-2.35%)
Nov 21, 2024, 3:49 PM EST - Market open
RAPT Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 37 | 855 | 672 | 1,085 | 485 | 603 | |
| Market Cap Growth | -87.71% | 27.19% | -38.08% | 123.77% | -19.54% | - | |
| Enterprise Value | -55 | 677 | 484 | 874 | 362 | 730 | |
| Last Close Price | 1.07 | 24.85 | 19.80 | 36.73 | 19.75 | 27.61 | |
| PS Ratio | - | - | 440.09 | 284.61 | 96.19 | - | |
| PB Ratio | 0.39 | 5.81 | 2.74 | 5.82 | 4.66 | 8.24 | |
| P/TBV Ratio | 0.73 | 5.81 | 2.74 | 5.82 | 4.66 | 8.24 | |
| EV/Sales Ratio | - | - | 317.25 | 229.33 | 71.83 | - | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.04 | - | - | - | |
| Asset Turnover | - | - | 0.01 | 0.02 | 0.05 | - | |
| Quick Ratio | 9.45 | 7.28 | 17.51 | 19.77 | 9.50 | 8.36 | |
| Current Ratio | 9.90 | 7.41 | 17.77 | 20.11 | 9.84 | 8.70 | |
| Return on Equity (ROE) | -80.13% | -59.56% | -38.85% | -47.63% | -59.66% | -62.71% | |
| Return on Assets (ROA) | -46.58% | -36.14% | -23.07% | -27.24% | -32.68% | -35.36% | |
| Return on Capital (ROIC) | -51.11% | -38.92% | -24.34% | -29.77% | -37.52% | -39.77% | |
| Earnings Yield | -287.37% | -13.66% | -12.48% | -6.38% | -10.91% | -7.13% | |
| FCF Yield | -269.49% | -11.49% | -10.66% | -5.69% | -8.43% | -6.03% | |
| Buyback Yield / Dilution | -2.72% | -17.82% | -18.80% | -13.49% | -455.27% | -598.45% | |
| Total Shareholder Return | -2.72% | -17.82% | -18.80% | -13.49% | -455.27% | -598.45% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.